Progyny, Inc.
PGNYHealthcareNASDAQHealthcare Plans · Last scanned Jul 18, 2026
Scan Results
Daily timeframeProgyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company carries a $2.50B market cap, placing it firmly in the mid-cap category. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists.
Market Cap
$2.50B
Beta
1.02
P/E (TTM)
41.47
P/E (Fwd)
14.21
EPS (TTM)
$0.77
EPS (Fwd)
$2.25
ROE
14.9%
ROA
9.1%
Cash
$225.1M
Total Debt
$27.3M
Free CF
$200.2M
52W Change
45.1%
Annual Financials
Cash vs Debt
The balance sheet looks solid with $225.1M in cash comfortably exceeding the $27.3M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $200.2M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 14.9% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 9.1% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $786.9M (2022) to $1.29B (2025), reflecting a 64% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Progyny, Inc. and its sector.